IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 277 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $214,000 | 0.0% | 3,536 | -1.1% | 0.01% | -16.7% |
| Q3 2019 | $214,000 | -6.1% | 3,576 | +1.0% | 0.01% | +9.1% |
| Q2 2019 | $228,000 | -2.1% | 3,541 | -18.0% | 0.01% | -35.3% |
| Q4 2018 | $233,000 | +4.5% | 4,316 | 0.0% | 0.02% | +41.7% |
| Q3 2018 | $223,000 | -98.3% | 4,316 | -98.4% | 0.01% | -97.3% |
| Q4 2016 | $13,101,000 | +30.5% | 273,900 | 0.0% | 0.45% | +36.8% |
| Q3 2016 | $10,036,000 | +57.3% | 273,900 | 0.0% | 0.33% | +41.2% |
| Q2 2016 | $6,379,000 | -33.3% | 273,900 | +16.1% | 0.23% | -33.0% |
| Q1 2016 | $9,558,000 | -27.2% | 236,000 | +11.3% | 0.35% | -23.0% |
| Q4 2015 | $13,129,000 | – | 212,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |